Agilent Technologies insider files holdings and 4,891-share option grant

Rhea-AI Filing Summary

Agilent Technologies, Inc. reported insider equity holdings and stock options for a senior executive. A Senior Vice President beneficially owns 1,675 shares of Agilent common stock in direct form. The executive also holds an employee stock option to buy 4,891 shares of common stock at an exercise price of $116.98 per share, granted under the Agilent Technologies, Inc. 2018 Stock Plan in compliance with Rule 16b-3. The option has an expiration date of 03/31/2035 and is scheduled to vest in four equal annual installments, beginning on the first anniversary of the grant date, with 03/31/2026 stated as the first vesting date. All reported holdings are listed as directly owned.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Henson Meghan

Role Senior Vice President

Type	Security	Shares	Price	Value
holding	Employee Stock Option (Right to Buy)	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 4,891 shares (Direct); Common Stock — 1,675 shares (Direct)

Footnotes (1)

1. Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Henson Meghan

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD.

(Street)

SANTA CLARA CA 95051

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/18/2025

3. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,675	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)(1)	03/31/2026(2)	03/31/2035	Common Stock	4,891	$116.98	D

Explanation of Responses:

1. Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3.

2. The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated.

Remarks:

See Exhibit 24 - Power of Attorney

	/s/ Bret DiMarco, attorney-in-fact for Ms. Henson	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider holdings were reported for Agilent Technologies (A)?

A Senior Vice President of Agilent Technologies, Inc. reported direct ownership of 1,675 shares of Agilent common stock and an employee stock option over additional shares.

How many Agilent (A) shares are covered by the reported stock option?

The employee stock option covers 4,891 shares of Agilent Technologies, Inc. common stock, as disclosed in the filing.

What is the exercise price of the Agilent (A) employee stock option?

The employee stock option has an exercise price of $116.98 per share for Agilent Technologies, Inc. common stock.

When do the Agilent (A) stock options start vesting and when do they expire?

The option vests in four equal annual installments beginning on the first anniversary of the grant, with 03/31/2026 stated as the first vesting date, and expires on 03/31/2035.

Under which plan were the Agilent (A) stock options granted?

The stock options were granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3.

Is the insider ownership in Agilent (A) direct or indirect?

Both the 1,675 shares of common stock and the employee stock option for 4,891 shares are reported as direct ownership.